Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fighting the Next Battle on Comparative Effectiveness: Creating Consensus Around Standards

This article was originally published in RPM Report

Executive Summary

The fight over comparative effectiveness research is taking place but the focus should be around creating standards.

You may also be interested in...



Comparative Effectiveness: Knowledge Not Coverage

The health industry's trade association supports a more formal and expanded federal comparative effectiveness research effort, with one caveat: the effort must be devoted to collecting and disseminating informaiton and not be tied directly to coverae or payment decisions. That aligns the health plans with Senate Finance Committee Chairman Max Baucus and creates a potent base for getting comparative effectiveness into upcoming health reform efforts.

Comparative Effectiveness: The Next Gatekeeper to Commercial Success

The hot new buzzword with policymakers is comparative clinical effectiveness, and everyone has an idea on how to make it work. But major questions remain: what might a national effort look like? And will payors use it to restrict access to new drugs?

Specialty Drug Tier: When Special Means Expensive

Medicare led the way to create a policy that’s just plain mean. Is there any way back?

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS080579

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel